Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer

Clinical trial NCT04352777 · COMPLETED

Trial details

NCT number: NCT04352777
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Locally Advanced Breast Cancer Hormone Receptor Positive Tumor

Start date: 2020-09-14
Primary completion: 2025-06-25
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.